These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32493526)

  • 1. Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy.
    Namiranian D; Chalk C; Massie R
    Can J Neurol Sci; 2020 Nov; 47(6):816-819. PubMed ID: 32493526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
    Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M
    Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
    Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
    Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
    Lee YJ; Oh J; Hwang SK; Lee EJ; Yang DH; Kim YJ; Kwon S; Hyun MC
    Neuropediatrics; 2019 Oct; 50(5):322-326. PubMed ID: 31319424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review.
    Martens B; De Pauw M; De Bleecker JL
    Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population.
    Lavigne-Moreira C; Marques VD; Gonçalves MVM; de Oliveira MF; Tomaselli PJ; Nunez JC; do Nascimento OJM; Barreira AA; Marques W
    J Peripher Nerv Syst; 2018 Jun; 23(2):134-137. PubMed ID: 29520877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
    Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
    Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
    Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
    Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
    J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".
    Grandis M; Geroldi A; Gulli R; Manganelli F; Gotta F; Lamp M; Origone P; Trevisan L; Gemelli C; Fabbri S; Schenone A; Tozza S; Santoro L; Bellone E; Mandich P
    Orphanet J Rare Dis; 2018 Oct; 13(1):177. PubMed ID: 30286783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy.
    Palha JA; Moreira P; Olofsson A; Lundgren E; Saraiva MJ
    J Mol Med (Berl); 2001; 78(12):703-7. PubMed ID: 11434723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
    Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD
    Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
    Parman Y; Adams D; Obici L; Galán L; Guergueltcheva V; Suhr OB; Coelho T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S3-S13. PubMed ID: 26734951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.